Document is current
Any future updates will be listed below
-
Authors
Prasad, Sandip M.
Louie, Michael J.
Burger, Brent
Tsurutis, Victoria
Ugwuoke, Nikky
Strauss-Ayali, Dalit
-
Funding
Funding for this research was provided by:
UroGen Pharma
- License Information
-
More Information
Article History
Received: 19 March 2025
Accepted: 16 September 2025
First Online: 11 October 2025
Declarations
:
: SMP has received PI funding from Janssen, Merck, Pfizer, and UroGen Pharma. DSA, VT, MK, MJL, BB, and NU are UroGen Pharma employees, and may hold stock and/or stock options in the company.
: This study was conducted in accordance with the International Conference on Harmonization Good Clinical Practice and the Declaration of Helsinki and was approved by the designated ethics committees and institutional review boards at each study site.
: All study participants provided written informed consent.
